By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ThromboGenics NV 

Gaston Geenslaan 1

Heverlee    B-3001  Belgium
Phone: 32-0-16-751310 Fax: 32-0-16-751311


Company News
ThromboGenics NV (TBGNF)' JETREA Receives Positive Recommendation From Scottish Medicines Consortium (SMC) 8/11/2014 10:53:02 AM
ThromboGenics NV (TBGNF)' JETREA Nominated For 2014 Prix Galien USA 7/31/2014 10:49:20 AM
ThromboGenics NV (TBGNF) Rules Out Sale, CFO Calls It Quits 6/24/2014 5:57:48 AM
Novartis AG (NVS), Shire Weighing $1.3 Billion Offer For ThromboGenics NV (TBGNF) 4/15/2014 8:02:48 AM
Flailing ThromboGenics NV (TBGNF) Considering Strategic Options 2/24/2014 8:04:47 AM
ThromboGenics NV (TBGNF)' Founder Prof Desire Collen Retiring As Chairman 12/9/2013 6:51:51 AM
ThromboGenics NV (TBGNF)' JETREA® Nominated for 2013 Prix Galien USA 10/21/2013 8:12:43 AM
Germany's G-BA Confirms That ThromboGenics NV (TBGNF)' JETREA® Demonstrates Significant Therapeutic Benefits for Vitreomacular Traction (VMT) Patients, Including When Associated With Macular Hole 10/18/2013 9:37:51 AM
ThromboGenics NV (TBGNF) Establishes Level 1 ADR Program for US Investors 9/30/2013 8:34:09 AM
ThromboGenics NV (TBGNF) Grabs Exclusive Rights to Bicycle Therapeutics Limited's Eye Treatment Technology 9/5/2013 7:12:11 AM